Angiodynamics (ANGO) EBIT (QoQ) (2010 - 2026)
Analysis
Angiodynamics (ANGO) EBIT (QoQ) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.94 Bn | 175.34 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.83 Bn | 122.62 Bn | 1.96 Bn |
| 3 | Medtronic | 116.96 Bn | 108.14 Bn | 6.34 Bn |
| 4 | Stryker | 104.44 Bn | 100.97 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.87 Bn | 63.33 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.91 Bn | 45.65 Bn | 1.35 Bn |
| 7 | Alcon | 33.06 Bn | 31.60 Bn | 1.68 Bn |
| 8 | Dexcom | 32.22 Bn | 30.27 Bn | 830.00 Mn |
| 9 | Steris | 20.68 Bn | 20.20 Bn | 684.20 Mn |
| 10 | Angiodynamics | 626.63 Mn | 572.76 Mn | 46.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 21.28% |
| Feb 28, 2026 | -111.44% |
| Nov 30, 2025 | 42.52% |
| Aug 31, 2025 | -84.11% |
| May 31, 2025 | 41.97% |
| Feb 28, 2025 | 10.10% |
| Nov 30, 2024 | 15.30% |
| Aug 31, 2024 | 9.35% |
| May 31, 2024 | 92.77% |
| Feb 29, 2024 | -1,423.60% |
| Nov 30, 2023 | -137.45% |
| Aug 31, 2023 | 268.11% |
| May 31, 2023 | -133.39% |
| Feb 28, 2023 | -10.02% |
| Nov 30, 2022 | 38.99% |
| Aug 31, 2022 | -107.93% |
| May 31, 2022 | -20.81% |
| Feb 28, 2022 | 38.99% |
| Nov 30, 2021 | -7.15% |
| Aug 31, 2021 | 62.48% |